These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 11999801)
1. New developments in influenza vaccine technology: a potential new prevention strategy for employers and managed care organizations. Williams JP; Lednar W Am J Manag Care; 2002 Apr; 8(5 Suppl):S143-54. PubMed ID: 11999801 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B; Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851 [TBL] [Abstract][Full Text] [Related]
4. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279 [TBL] [Abstract][Full Text] [Related]
5. Current status of live attenuated influenza virus vaccine in the US. Belshe RB Virus Res; 2004 Jul; 103(1-2):177-85. PubMed ID: 15163507 [TBL] [Abstract][Full Text] [Related]
6. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008. American Academy of Pediatrics Committee on Infectious Diseases Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500 [TBL] [Abstract][Full Text] [Related]
7. Universal influenza vaccination in the United States: are we ready? Report of a meeting. Schwartz B; Hinman A; Abramson J; Strikas RA; Allred N; Uyeki T; Orenstein W J Infect Dis; 2006 Nov; 194 Suppl 2():S147-54. PubMed ID: 17163388 [TBL] [Abstract][Full Text] [Related]
8. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children. Belshe RB; Gruber WC Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396 [TBL] [Abstract][Full Text] [Related]
9. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511 [TBL] [Abstract][Full Text] [Related]
10. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344 [TBL] [Abstract][Full Text] [Related]
13. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Ryan J; Zoellner Y; Gradl B; Palache B; Medema J Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Tam JS; Capeding MR; Lum LC; Chotpitayasunondh T; Jiang Z; Huang LM; Lee BW; Qian Y; Samakoses R; Lolekha S; Rajamohanan KP; Narayanan SN; Kirubakaran C; Rappaport R; Razmpour A; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2007 Jul; 26(7):619-28. PubMed ID: 17596805 [TBL] [Abstract][Full Text] [Related]
16. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
17. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Bergen R; Black S; Shinefield H; Lewis E; Ray P; Hansen J; Walker R; Hessel C; Cordova J; Mendelman PM Pediatr Infect Dis J; 2004 Feb; 23(2):138-44. PubMed ID: 14872180 [TBL] [Abstract][Full Text] [Related]
18. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577 [TBL] [Abstract][Full Text] [Related]
20. Could a federal program to promote influenza vaccination among elders be cost-effective? Patel MS; Davis MM Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]